Institutional Ownership
Impact Biomedical Inc
CUSIP 45259L205COMMON STOCKIBOQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
17
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Geode Capital Management, LLC | 1.19M | $716.2K |
| 2 | State Street Corp | 607.9K | $364.7K |
| 3 | Blackrock, Inc. | 259.9K | $156.0K |
| 4 | Northern Trust Corp | 243.9K | $146.4K |
| 5 | Two Sigma Investments, LP | 37.4K | $22.5K |
| 6 | Ubs Group AG | 32.4K | $19.4K |
| 7 | Mason & Associates Inc | 10.0K | $5.9K |
| 8 | Morgan Stanley | 9.3K | $5.6K |
| 9 | Global Trust Asset Management, LLC | 1.8K | $1.1K |
| 10 | Citigroup Inc | 353 | $212 |